4//SEC Filing
Beardsley Robert A 4
Accession 0000899243-19-027114
CIK 0001563577other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:15 PM ET
Size
11.3 KB
Accession
0000899243-19-027114
Insider Transaction Report
Form 4
Beardsley Robert A
Chief Operating Officer
Transactions
- Conversion
Series A Preferred Stock
2019-11-12−68,907→ 0 total→ Common Stock (13,627 underlying) - Conversion
Series C Preferred Stock
2019-11-12−6,774→ 0 total→ Common Stock (1,339 underlying) - Conversion
Common Stock
2019-11-12+15,361→ 68,191 total - Conversion
Series B Preferred Stock
2019-11-12−2,000→ 0 total→ Common Stock (395 underlying)
Footnotes (1)
- [F1]Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001310845
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:15 PM ET
- Size
- 11.3 KB